Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Arcadia Biosciences, Inc. (RKDA : NSDQ)

• Company Description    Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $4.82 Daily Weekly Monthly 20 Day Moving Average: 17,901 shares Shares Outstanding: 1.37 (millions) Market Capitalization: $6.59 (millions) Beta: 0.50 52 Week High: $7.08 52 Week Low: $2.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.20% -4.90% 12 Week 63.15% 37.23% Year To Date -18.58% -23.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5950 Sherry Lane SUITE 215 - Dallas,TX 75225 USA ph: 214-974-8921 fax: 530-756-7027 ir@arcadiabio.com http://www.arcadiabio.com

• General Corporate Information    Officers Thomas J. Schaefer - President and Chief Executive Officer Mark Kawakami - Chief Financial Officer Albert D. Bolles - Director Kevin Comcowich - Director Lilian Shackelford Murray - Director Peer Information Arcadia Biosciences, Inc. (CORR.) Arcadia Biosciences, Inc. (RSPI) Arcadia Biosciences, Inc. (CGXP) Arcadia Biosciences, Inc. (BGEN) Arcadia Biosciences, Inc. (GTBP) Arcadia Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 039014303 SIC: 1311 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 1.37 Most Recent Split Date: 3.00 (0.03:1) Beta: 0.50 Market Capitalization: $6.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.74 Price/Cash Flow: - Price / Sales: 1.25 EPS Growth vs. Year Ago Period: 206.74% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -4.38% vs. Previous Quarter: -1.23% ROE 06/30/25 - - 03/31/25 - -16.94 12/31/24 - -68.53 ROA 06/30/25 - - 03/31/25 - -10.56 12/31/24 - -42.35 Current Ratio 06/30/25 - - 03/31/25 - 3.99 12/31/24 - 3.61 Quick Ratio 06/30/25 - - 03/31/25 - 3.41 12/31/24 - 3.25 Operating Margin 06/30/25 - - 03/31/25 - -29.67 12/31/24 - -123.89 Net Margin 06/30/25 - - 03/31/25 - -38.34 12/31/24 - -132.47 Pre-Tax Margin 06/30/25 - - 03/31/25 - -14.51 12/31/24 - -85.41 Book Value 06/30/25 - - 03/31/25 - 6.51 12/31/24 - 4.56 Inventory Turnover 06/30/25 - - 03/31/25 - 3.17 12/31/24 - 2.61 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©